Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Two posters presented at the CHEST 2024 annual meeting underscore the importance of early identification and treatment of ...

Key Takeaways Regeneron and Sanofi shares edged higher Friday after their drug to treat chronic obstructive pulmonary disease ...

The US Food and Drug Administration has approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic ...

Ted Koppel and his wife, Grace Anne Dorney Koppel — who was told she only had a few years left to live after her 2001 COPD ...

The global airway disease treatment market is projected to experience significant growth over the next decade, with revenue ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses the potential of tailored treatment strategies and the importance of smoking cessation.

“You can live a very fulfilling life with COPD and don’t have to be held back by this disease,” he explains. “But being active in your treatment journey is key.” Throughout his COPD journey, Gordon ...

Oct. 2, 2024 — The FDA has approved Regeneron and Sanofi’s drug Dupixent for patients with COPD (chronic obstructive pulmonary disease). Marking the sixth indication for the drug, the approval ...